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INTRODUCTION
In healthy women, the menstrual cycle and
reproductive health depend on the balance
between the hormones formed by the hypotha-
lamus and the pituitary. The hypothalamus will
produce gonadotropin-releasing hormone (Gn-
RH), this hormone will control the release of
hormones released by the pituitary luteinizing
hormone (LH) and follicle stimulating hormone
(FSH). FSH and LH play a role in follicular
maturation, ovulation and corpus luteum forma-
tion and synthesis of sex steroids.1
Abstract
Objective: To determine the relationship between elevated serum
retinol-binding protein 4 with abnormal uterine bleeding.
Methods: This study was an observational quantitative with cross-
sectional methods, with all women who had abnormal uterine
bleeding caused either by endometrial carcinoma or endometrial
hyperplasia at RSUP Prof. Dr. R.D. Kandou, and affiliation hospitals
from November 2016 until April 2017. Data were analysed with
SPSS version 2.0 to see the significance level.
Results: Of 26 research subjects, 23 subjects with endometrial
hyperplasia and three subjects with endometrial carcinoma. From
the total of 26 malignancy and hyperplasia diagnoses, 21 had IMT >
25, and 23 were diagnosed with Endometrial Hyperplasia and 3
Carcinoma Endometrium. 18 subjects had elevated serum RBP4
levels, with 15 people with endometrial hyperplasia and 3 with
endometrial carcinoma. With the Fischer Exact test statistic, serum
retinol binding protein 4 levels were found in both endometrial
hyperplasia and endometrial carcinoma p = 1.00, meaning no
significant difference for the occurrence of abnormal uterine
bleeding.
Conclusion: There was no significant association between serum
retinol binding protein 4 between endometrium carcinoma and
endometrial hyperplasia.
[Indones J Obstet Gynecol 2018; 6-4: 243-247]
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Abstrak
Tujuan: Mengetahui adanya hubungan peningkatan kadar serum
retinol binding protein 4 pada hyperplasia endometrium dengankarsinoma endometrium.
Metode: Penelitian ini adalah jenis kuantitatif observasional secarapotong lintang, dengan semua perempuan yang mengalami
perdarahan uterus abnormal yang disebabkan oleh hiperplasia
endometrium atau karsinoma endometrium di Obstetri danGinekologi Rumah Sakit Umum Pusat (RSUP) Prof. Dr. R.D. Kandou,
dan RS jejaring mulai November 2016 sampai April 2017. Datadia na lisa  deng a n SPSS versi 2.0 untuk meliha t  t ing ka t
kemaknaannya.
Hasil: Dari 26 subjek penelitian, 23 subjek dengan hiperplasia
endometrium dan 3 subjek dengan karsinoma endometrium.
Didapatkan data penelitian dari total keganasan diagnosa danhiperplasia sejumlah 26 orang, sebanyak 21 orang memiliki IM T>25
dan sebanyak 23 orang didiagnosa dengan Hiperplasia Endometriumdan 3 orang karsinoma endometrium. Didapatkan sebanyak 18 subjek
penelitian mengalami peningkatan kadar serum RBP 4, dengan 15
orang yang mengalami hiperplasia endometrium dan 3 orang dengankarsinoma endometrium. Dengan uji statistik Fischer Exact test,
didapatkan kadar serum retinol binding protein 4 baik pada
hiperplasia endometrium dengan karsinoma endometrium p=1.00,mengartikan tidak mempunyai perbedaan bermakna untuk
terjadinya perdarahan uterus abnormal.
Kesimpulan: Tidak terdapat hubungan bermakna kadar serum
retinol binding protein 4 antara karsinoma endometrium denganhiperplasia endometrium.
[Maj Obstet Ginekol Indones 2018; 6-4: 243-247]
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In reproductive-aged women, the reproductive
and endocrine organs are functioning perfectly,
at the age of perimenarche the hypothalamic-
pituitary and ovarian axis are immature while at
perimenopause the organ function begins to
decline. Based on nutritional status, women with a
BMI> 25 have a higher risk of menstrual cycle
disturbance than women with nutritional status
<25.1
RBP 4 is identified as one molecule of adipose
molecule derivatives that contributes to the cause
of insulin resistance in obesity and type 2 diabetes
mellitus. RBP will cloak directly on objects with
obesity or glucose intolerance, type 2 diabetes or
with risk factors for cardiovascular pathology dis-
orders.2
RBP4 is a protein compound derived from the
lipocalin group and is a carrier-specific protein for
retinol (vitamin A alcohol) in the blood. This
compound will deliver retinol from the storage of
the liver and then distributed throughout the body
tissues. In plasma, the RBP 4 complex will bind to
the transthyretin complex and will be filtered by
the renal glomerulus. Lack of this RBP will affect
vitamin A levels and distribution to all cells.2
Based on the background of changes in estrogen
levels in women with abnormal uterine bleeding
(PUA), malignancy and endometrial hyperplasia
in which estrogen levels will be affected by nutri-
tional status which is a representation of adipose
tissue it is necessary to do research on levels of
Retinol Binding Protein 4 (RBP4) in patients
Abnormal Uterine Bleeding (PUA) malignancy and
endometrial hyperplasia to aid in more accurate
diagnosis and management.
METHODS
This was a cross-sectional study, with all women
who had abnormal uterine bleeding caused either
by endometrial carcinoma or endometrial hyper-
plasia at RSUP Prof. Dr. R.D. Kandou, and affiliation
hospitals from November 2016 until April 2017.
Data were analysed With SPSS version 2.0 to see
the significance level.
Data collection was performed by following
steps: Patients who meet the inclusion criteria are
given an explanation of the action to be performed
and the patient signs the consent statement
following the research provided. Subject of this
research is anamnesis, physical examination and
then recorded in research status. Venous blood
taken for RBP4 was examined, then reversed
slowly about 5-10 times. Immediately within 30
minutes, the sample was centrifuged at 1000 g at
a speed of about 3000 rpm for 15 minutes then the
serum obtained was stored in a refrigerator with
a temperature of -200C and then sent to Jakarta by
using Ice pack to maintain the storage temperature
before the examination of RBP 4 in the Laboratory
Prodia Jakarta. Examination of serum RBP 4 level
was done by quantitative method, using ELISA
method.
Table 1. Distribution of Research Subject Characteristic
Characteristic
BMI > 25 BMI < 25
total
n % n %
Age
> 40 18 81.81 4 18.18 22
< 40 3 75 1 25 4
Education
Elementary 1 50 1 50 2
Junior high school 2 40 3 60 5
High school 15 93.75 1 6.25 16
Diploma 2 100 0 - 2
Bachelor 1 100 0 - 1
Occupation
Civil 1 100 0 - 1
Private 20 92.64 5 7.35 25
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RESULTS
From above data, it is found that the most age
group obtained is at the age of 40 years (22 people)
with 18 people have BMI >25. While the highest
education status is high school with 15 subjects. A
total of 20 subjects were private employees, and
only one subject works as a civil servant.
Of the total 26 malignancy and hyperplasia
diagnoses, 21 had a BMI of > 25 and 23 were
diagnosed with Endometrial Hyperplasia and 3
Endometrial Carcinomas. 18 subjects had elevated
serum RBP4 levels,  with 15 people with
endometrial hyperplasia and 3 with endometrial
carcinoma.
DISCUSSION
RBP 4 is identified as one molecule of adipose
molecule derivatives that contributes to causing
insulin resistance in obesity and type 2 diabetes
mellitus. RBP will correlate directly to objects with
obesity or glucose intolerance, type 2 diabetes or
with risk factors for cardiovascular pathology dis-
orders.2
As a system for retinol transport, a specific
protein retinol binding will be produced in the liver
and will mobilise retinol from the liver as the
primary storage area. Once excreted from the liver,
the retinol binding protein complex will circulate
in the blood further binding to the plasma
transthyretin. When retinol has reached the target
tissue, the bone-specific retinol-free protein will be
rapidly catabolized and excreted in the kidneys.
The turning point of biological retinol binding
protein has a half-life of 11.5 hours in adult
humans.2
In Table 1. Characteristics of the subjects are
seen by age, occupation, education, BMI and basic
aetiology of AUB-M. All samples were patients who
had been diagnosed with AUB-M. In Table 1 it was
found that the most age group obtained was at the
age of 40 years (22 people) with 18 of them had
IMT > 25. While the highest education status was
high school with 15 samples. A total of 25 samples
have private employment, and only one person
works as a civil servant. According to Kovacs P.
2012. Endometrial bleeding will be more common
at age  40 years than in women <40 years. Age
40 years is the beginning of perimenopausal age.
Where at age 40 a woman will be more frequent
to occur anovulation and based on it at age 40
menstrual cycle will be longer. In research in
Australia, when the menstrual cycle has exceeded
42 days, menopause can be predicted to occur
within 1 to 2 years. The duration of the follicular
phase is the determinant of the length of the cycle.
As discussed in the literature review, there are 2
estrogen receptors that simultaneously affect the
body’s estrogen levels. One of the estrogen
receptors derived from the ovaries (E2 receptors)
so that researchers need to choose the conditions
in which E1 receptors (skin, fat, muscle, endo-
metrium) can be assessed as a major factor in this
study.2-6
In Table 2, the largest distribution of research
samples obtained aetiology of endometrial
hyperplasia and endometrial carcinoma is 26
people and of that 21 people have IMT > 25 and
as many as 18 people have serum RBP 4 > 26.000.
Adipose tissue is found on almost all body surfaces.
Corrected directly with the surface area of the body
which in this study is defined as the body mass
index. Increasing IMT means that the broader the
adipose network is owned by the individual. In the
event of AUB-M with the aetiology of malignancy
and hyperplasia has been explained and in the
aetiology endometrial has been suspected one of
the risk factors is the nutritional status, where
will be directly related to endometrial status.
Pathological nutrition status will affect the
occurrence of metabolic syndrome. And this will
affect the adipose network which will then affect
Table 2. Difference of serum RBP4 between Endometrial Hyperplasia and Endometrial Carcinoma
BMI > 25 BMI < 25
RBP 4 <26.800 ng/ml RBP 4 >26.800 ng/ml RBP 4 <26.800 ng/ml RBP 4 >26.800 ng/ml
Hyperplasia 3 15 3 2 23 p=1.00
Carcinoma 0 3 0 0 3
3 18 3 2 26
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the level of an individual RBP. In endometrial
hyperplasia with BMI < 25 serum RBP4 levels were
found in 3 people with serum RBP 4 <26.800. Then
at the RBP 4 level of endometrial hyperplasia
patients with BMI > 25, there were three subjects
with serum RBP 4 <26.800. This may be due to
many things, where elevated serum RBP 4
levels are affected by various factors such as
comorbidities, insulin sensitivity, dietary patterns,
and other lab variables not examined in this study.
The results of this study are consistent with those
reported by Kovacs, P 2012, obesity, a risk factor
often encountered in endometrial malignancies.6-10
Endometrial hyperplasia is a pathological
condition in the endometrium in the form of
increased proliferation of the endometrial glands
resulting in changes in the ratio of glands and
stroma, shape and size of the gland, the glandular
structure increases to 2-3 layers and has the
potential to be an atypical form of cells when there
is no balance of inhibitors and the initiator of the
proliferation of glandular cells.9-11
With the imbalance between estrogen and
progesterone where there is a state of Unopposed
Estrogen that will cause endometrial thickening.
Estrogen hormones known to be produced in the
ovaries are also produced on adipose tissue.
Adipose tissue has been known as the organ that
produces adipokine where one of the adipokines is
RBP4. With increased adipose tissue will be
associated with increased BMI.1 In Table 3 the
results of the Fischer exact test show p = 1.00. This
means there is no significant difference between
serum retinol binding levels of Protein 4 in
endometrial hyperplasia and endometrial carci-
noma. This may occur because in this study
increased serum RBP 4 levels obtained as many as
17 people with both endometrial hyperplasia and
endometrial carcinoma. Increased RBP 4 was
associated with BMI levels > 25 in this study there
were 21 people with BMI > 25. So that serum RBP
4 levels were > 50% increased by more than
26,800. So with the statistical test obtained p-value
= 1.00. So it can be said there is no significant
difference in serum RBP 4 levels between
endometrial hyperplasia and endometrial
carcinoma. While in BMI obtained in this study,
showed that with total samples of hyperplasia and
endometrial carcinoma with BMI > 25 were 21
people. Susanne et al. 2007, reported BMI
associated with serum RBP 4 levels, the higher
the BMI then serum RBP 4 levels will also increase.
In several other studies have also been done to see
the relationship between serum RBP4 and BMI
levels. This is in line with the results obtained in
this study where elevated serum RBP 4 levels in
BMI > 25 as many as 18 people. In addition, there
have been several studies linking RBP with insulin
resistance wherein insulin resistance will be asso-
ciated with Diabetes Mellitus type 2.12-16
This research has advantages and disadvan-
tages, the limitations that will be able to influence
the research results, such as the lack of research
samples, RBP in normal BMI patients and not
experiencing AUB-M, cannot control confounding
variables such as,  GDS, dietary patterns,
unexamined FSH-LH, estrogen, HOMA-IR levels.
Moreover, some other mediators whom other
studies have suspected will affect the results of our
research. While the advantages of this study were
all those examined were patients with AUB with
endometrial hyperplasia aetiology and endometrial
carcinoma, also this study used data obtained by
Anatomical Pathology and ultrasound. Another
advantage is that all samples were taken from
September 2016 to April 2017 so that it can be
used as an overview of PUA events with the
aetiology of malignancy and endometrial hyper-
plasia.16-18
CONCLUSION
There was a no correlation between serum RBP 4
between endometrial hyperplasia and endometrial
carcinoma.
SUGGESTION
Further studies with larger sample size and better
study design are required.
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